These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25624094)

  • 1. Immunotherapy for head and neck squamous cell carcinoma.
    Li Q; Prince ME; Moyer JS
    Oral Oncol; 2015 Apr; 51(4):299-304. PubMed ID: 25624094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in head and neck cancer: current practice and future possibilities.
    Agada FO; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune alterations and immunotherapy prospects in head and neck cancer.
    Varilla V; Atienza J; Dasanu CA
    Expert Opin Biol Ther; 2013 Sep; 13(9):1241-56. PubMed ID: 23789839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
    Bron L; Romero P
    Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for head and neck cancer: the future of treatment?
    Xie X; O'Neill W; Pan Q
    Expert Opin Biol Ther; 2017 Jun; 17(6):701-708. PubMed ID: 28368668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of head and neck cancer.
    Resser JR; Carbone DP
    Curr Opin Oncol; 1998 May; 10(3):226-32. PubMed ID: 9619359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for Head and Neck Squamous Cell Carcinoma.
    Schoppy DW; Sunwoo JB
    Hematol Oncol Clin North Am; 2015 Dec; 29(6):1033-43. PubMed ID: 26568546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Treatment Options in Head and Neck Cancer.
    Schuler PJ; Laban S; Doescher J; Bullinger L; Hoffmann TK
    Oncol Res Treat; 2017; 40(6):342-346. PubMed ID: 28521322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy.
    Bryan RB; Gough MJ; Seung SK; Jutric Z; Weinberg AD; Fox BA; Crittenden MR; Leidner RS; Curti B
    Oral Oncol; 2016 Oct; 61():166-76. PubMed ID: 27614589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy for head and neck squamous cell carcinoma].
    Bron L; Romero P
    Rev Med Suisse; 2006 Oct; 2(81):2216-9. PubMed ID: 17076151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy for head and neck squamous cell carcinoma].
    Chen J; Chen M; Wu HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 52(2):143-147. PubMed ID: 28219181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for Head and Neck Cancer.
    Sim F; Leidner R; Bell RB
    Oral Maxillofac Surg Clin North Am; 2019 Feb; 31(1):85-100. PubMed ID: 30449528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells and HNSCC: a potential treatment option? (Review).
    Dunn G; Oliver KM; Loke D; Stafford ND; Greenman J
    Oncol Rep; 2005 Jan; 13(1):3-10. PubMed ID: 15583794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunomodulation as innovative therapy for head and neck tumors : Current developments].
    Schuler PJ; Doescher JC; Laban S; Hoffmann TK
    HNO; 2016 Jul; 64(7):470-8. PubMed ID: 26912050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy for HNSCC : Quo vadis?].
    Döscher J; Busch CJ; Schuler PJ; Laban S
    HNO; 2016 Oct; 64(10):700-7. PubMed ID: 27624904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy of head and neck cancer. Current developments].
    Schuler PJ; Hoffmann TK; Gauler TC; Bergmann C; Brandau S; Lang S
    HNO; 2013 Jul; 61(7):559-72. PubMed ID: 23247754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase 1 safety study of an IRX-2 regimen in patients with squamous cell carcinoma of the head and neck.
    Freeman SM; Franco JL; Kenady DE; Baltzer L; Roth Z; Brandwein HJ; Hadden JW
    Am J Clin Oncol; 2011 Apr; 34(2):173-8. PubMed ID: 20539208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed?
    Ferris RL
    ORL J Otorhinolaryngol Relat Spec; 2004; 66(6):332-40. PubMed ID: 15668533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapeutic studies of head and neck tumors : Highlights of the 2016 ASCO Annual Meeting].
    Busch CJ; Laban S; Knecht R; Hoffmann TK
    HNO; 2016 Oct; 64(10):708-16. PubMed ID: 27604282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck.
    Mayer A; Andratschke M; Pauli C; Graefe H; Kristina K; Wollenberg B
    Anticancer Res; 2005; 25(6B):4075-80. PubMed ID: 16309201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.